AbbVie

Traded on the St. Petersburg Stock Exchange
AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories. AbbVie develops drugs and treatments for patients with age-related diseases, including neurodegeneration and various forms of cancer. The company employs around 30,000 people worldwide.
AbbVie stock price chart
vol.
change
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

AbbVie balance sheet

Report period2018 2019 2020 2021 2022 2023
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

AbbVie cash flows

Report period2018 2019 2020 2021 2022 2023
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

AbbVie multipliers

Report period2018 2019 2020 2021 2022 2023
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

AbbVie profitability

Report period2018 2019 2020 2021 2022 2023
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
AbbVie assets
AbbVie cash flows
AbbVie dividends
5.05%

AbbVie shares

TickerNameTypeNominal valueISINPrice
ABBV:USAbbVie Inc.Common share-US00287Y1091$178.4
AbbVie news
27.10.2023
AbbVie Board of Directors announced a quarterly dividend of $1.55 per share. The last day to buy securities to receive the dividend is January 12, 2024. The annual dividend yield may reach 5.17%.
Source: {source} pictogram news.abbvie.com
Pictogram next
27.10.2023
AbbVie's GAAP net income for 9 months of 2023 totaled $4.049 billion, down 2.3 times from $9.373 billion in the previous year. Revenue fell 6.8% to $40.017 billion from $42.933 billion a year earlier.
Source: {source} pictogram news.abbvie.com
Pictogram next
11.09.2023
The AbbVie Board of Directors announced a quarterly dividend of $1.48 per share. The last day to buy securities to receive the dividend is October 11, 2023. The annual dividend yield may reach 5.04%.
Source: {source} pictogram news.abbvie.com
Pictogram next
27.07.2023
AbbVie's GAAP net income for 6 months of 2023 totaled $2.268 billion, down 2.4 times from $5.421 billion in the previous year. Revenue declined 7.2% to $26.09 billion from $28.121 billion a year earlier.
Source: {source} pictogram investors.abbvie.com
Pictogram next
All AbbVie news
General information
Company nameAbbVie
Tags#pharmacy, #dividend aristocrats, #s&p500 index
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals
Business address1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
Mailing address1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Websiteinvestors.abbvie.com
Information disclosurewww.sec.gov